Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HPI Effect in Robotic Urological Surgery on AKI

NCT: NCT06051162 · COMPLETED

NCT IDNCT06051162
StatusCOMPLETED
Start Date2023-11-07
Completion2025-04-10
SponsorEwha Womans University Mokdong Hospital (OTHER)
First posted
Last updated

Brief Summary

It is a single-center randomized controlled trial that aims to figure out the effect of the hypotension prediction index (HPI) on the prevention of acute kidney injury (AKI) after robot-assisted urological surgery. The primary hypothesis is that HPI software guidance prevents postoperative AKI by reducing the duration and severity of intraoperative hypotension (IOH).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑